CFDE Data Portal | Search SLC6A14

	Label	Description
	SLC6A14 Gene (Entity type)	ENSG00000268104 - solute carrier family 6 member 14
	SLC6A14 associations Collection (Entity type)	Associations for SLC6A14_associations
	SLC6A14 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GSE135514 8 V 7 DASATINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 6 V 10 CRIZOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE200982 PLAC8 knockout 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE165334 2 V 0 DABRAFENIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE169152 3 V 6 IBRUTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE149901 3 V 1 ANLOTINIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

SLC6A14

ENSG00000268104 - solute carrier family 6 member 14

SLC6A14 associations

Associations for SLC6A14_associations

SLC6A14 associations.tsv

A file from IDG as part of the Harmonizome project

GSE135514 8 V 7 DASATINIB HUMAN DN

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up

A Gene Set from LINCS

GSE239844 6 V 10 CRIZOTINIB HUMAN DN

A Gene Set from LINCS

GSE200982 PLAC8 knockout 0 v 2 human dn

A Gene Set from LINCS

GSE165334 2 V 0 DABRAFENIB HUMAN UP

A Gene Set from LINCS

GSE169152 3 V 6 IBRUTINIB HUMAN DN

A Gene Set from LINCS

GSE149901 3 V 1 ANLOTINIB HUMAN DN

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.